Anthelmintic Macrolactams from Nonomuraea turkmeniaca MA7364

Sloan Ayers, Deborah L. Zink, Kenneth Mohn, Joanne Staats Powell, Christine M. Brown, Terry Murphy, Alan Grund,§ Olga Genilloud, Oscar Salazar, Donald Thompson, and Sheo B. Singh*
Natural Products Chemistry, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065, Merck and Co., Inc., Branchburg Farm, 203 River Road, Somerville, New Jersey 08876, Bio-Technical Resources, 1035 South 7th Street, Manitowoc, Wisconsin 54220, and Centro de Investigacin Bsica, Merck, Sharp & Dohme de Espana, S.A., Josefa Valcarcel 38, 28027 Madrid, Spain
J. Nat. Prod., 2007, 70 (8), pp 1371–1373
DOI: 10.1021/np070131e
Publication Date (Web): July 18, 2007
Copyright © 2007 American Chemical Society and American Society of Pharmacognosy

 Natural Products Chemistry, MRL.

,

 Branchburg Farm.

,
§

 Bio-Technical Resources.

,

 CIBE.

,
*

 To whom correspondence should be addressed. Tel:  (732) 594-3222. Fax:  (732) 594-6880. E-mail:  sheo_singh@merck.com.

Abstract

Abstract Image

Two new macrolactams, 6-desmethyl-N-methylfluvirucin A1 (1) and N-methylfluvirucin A1 (2), have been isolated from the acetone extract of Nonomuraea turkmeniaca MA7364. These compounds were isolated by bioassay-guided fractionation as part of our search for new anthelmintics. The structures of these compounds were elucidated by comparison of their NMR and MS data to those of previously reported fluvirucins and confirmed by 2D NMR. Compound 1 exhibited in vitro activity (EC90 15 ± 5 μg/mL) against Haemonchus contortus larvae, whereas compound 2, while a bit less active in vitro (EC90 29 ± 8 μg/mL), showed modest in vivo activity against a surrogate organism, Heligmosomoides polygyrus in mice, at 50 mg/kg.

Tools

History

  • Published In Issue August 24, 2007
  • Received March 26, 2007

Recommend & Share

Related Content

Other ACS content by these authors: